Tüdőrák: vizsgálatok itt: Brazília
68 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Where
- Barretos, Porto Alegre, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07286149 · EU 2024-512248-47-00 - 3. fázisTaking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Barretos, Belo Horizonte, Porto Alegre, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00 - 3. fázisTaking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Where
- Blumenau, Fortaleza, Ijuí, Itajaí, Londrina, Passo Fundo, Porto Alegre, Porto Velho, Salvador, Santo André, São Paulo, Teresina
- Életkor
- 18 év and over
- People
- 830 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00 - No phaseTaking peopleRACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
- Where
- Belo Horizonte, Natal, Porto Alegre, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 250
- Run by
- AstraZeneca
See details and how to joinNCT06491862 - 3. fázisTaking peopleA Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Where
- São Paulo
- Életkor
- 18 év and over
- People
- 531 worldwide
- Run by
- AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00 - 2. fázisTaking peopleMetabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
- Where
- Ribeirão Preto
- Életkor
- 18 év and over
- People
- 30
- Run by
- Hospital das Clínicas de Ribeirão Preto
See details and how to joinNCT07084610 - 1/2. fázisTaking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Barretos, Porto Alegre, Salvador, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - No phaseNot yet taking people in BrazíliaLung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
- Where
- Rio de Janeiro
- Életkor
- 50 év to 80 év
- People
- 477
- Run by
- AstraZeneca
See details and how to joinNCT07279948 - No phaseFut, nem toborozNeuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
- Where
- Belo Horizonte, Cachoeiro de Itapemirim, Campo Grande, Curitiba, Lages, Londrina, Natal, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Latin American Cooperative Oncology Group
See details and how to joinNCT07192991 - No phaseTaking peopleLung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
- Where
- Botucatu
- Életkor
- 45 év to 74 év
- People
- 1000
- Run by
- AstraZeneca
See details and how to joinNCT06376097 - 3. fázisTaking peoplePhase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Barretos, Natal, Porto Alegre, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 582 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00 - 2. fázisTaking peopleA Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
- Where
- Barretos, Belo Horizonte, Fortaleza, Itajaí, Natal, Porto Alegre, Recife, Rio de Janeiro, Salvador, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 46
- Run by
- Latin American Cooperative Oncology Group
See details and how to joinNCT06822543 - 3. fázisTaking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Barretos, Florianópolis, Itajaí, Porto Alegre, Santo André, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - No phaseTaking peopleDeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
- Where
- Recife, Rio de Janeiro, Salvador, São Paulo
- People
- 200
- Run by
- AstraZeneca
See details and how to joinNCT07109154 - 1. fázisTaking peoplePhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Barretos, Porto Alegre, São Paulo
- Életkor
- 18 év and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - 2. fázisTaking peopleEfficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
- Where
- São José do Rio Preto
- Életkor
- 18 év and over
- People
- 33
- Run by
- Aline Fusco Fares, MD
See details and how to joinNCT06667154 - 2. fázisTaking peopleEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
- Where
- São Paulo
- Életkor
- 16 év and over
- People
- 100
- Run by
- AC Camargo Cancer Center
See details and how to joinNCT06472388 - No phaseNot yet taking people in BrazíliaProtocol for Accelerated Recovery in Patients Undergoing Thoracic Surgical Procedures (PROSM). Study Randomized Comparative Between the Adoption of the Proposed Guidelines and the Traditional Method Currently Used in the Institution
- Where
- São Paulo
- Életkor
- 18 év and over
- People
- 200
- Run by
- Igor Renato Louro Bruno de Abreu
See details and how to joinNCT03271749